Prostate Cancer - Results from #28240

Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? - Abstract April 19, 2011

The short-term use of erythropoetin-stimulating agents: Impact on the biochemical recurrence of prostate cancer - Abstract April 19, 2011

Radical perineal prostatectomy: An outdated procedure? - Abstract April 19, 2011

Salvage radiation in men after prostate-specific antigen failure and the risk of death - Abstract April 18, 2011

The endocannabinoid system in the cancer therapy: An overview - Abstract April 18, 2011

Prognostic role of perineural invasion in prostate biopsy - Abstract April 18, 2011

Clinically relevant fatigue in recurrence-free prostate cancer survivors - Abstract April 18, 2011

Minireview: Alternative activation pathways for the androgen receptor in prostate cancer - Abstract April 18, 2011

Clinical versus pathologic staging for prostate adenocarcinoma: How do they correlate? - Abstract April 18, 2011

PSA density versus risk stratification for lymphadenectomy-making decision in patients with prostate cancer undergoing radical prostatectomy - Abstract April 18, 2011

High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients - Abstract April 18, 2011

CURy 2011 - Abiraterone acetate in castration-resistant prostate cancer - Slide Presentation April 18, 2011

Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: Long-term effect on biochemical control-in search of the optimal treatment - Abstract April 15, 2011

Salvage lymphadenectomy in postprostatectomy patients with prostate-specific antigen recurrence - Abstract April 15, 2011

The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivation - Abstract April 15, 2011

The effect of demographic and clinical factors on the relationship between BMI and PSA levels - Abstract April 15, 2011

A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer - Abstract April 15, 2011

Constitutional risk factors in prostate cancer - Abstract April 15, 2011

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: Tumor detection and assessment of aggressiveness - Abstract April 15, 2011

Penile implant utilization following treatment for prostate cancer: Analysis of the SEER-Medicare database - Abstract April 14, 2011

Page 1413 of 1437